logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Little benefit from switch maintenance therapy in elderly patients with advanced NSCLC

Although therapy yielded better PFS, there was no OS benefit and greater toxicity.